NSE filing, NSE: INDRAMEDCO. Summary written from the filing by ALFA Finder's alert engine.
Indraprastha Medical Corporation Ltd: key numbers
- Share price
- ₹313.60
- Market cap
- ₹2,875 Cr
- Revenue (annual)
- ₹1,483 Cr
- Net profit (annual)
- ₹183.6 Cr
- P/E (TTM)
- 15.3×Sector 52.0×
- Promoter holding
- 51.00%+0.00% QoQ
- FII holding
- 2.39%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Indraprastha Medical Corporation Ltd
All →Indraprastha Medical Corporation Board Meeting Date
Indraprastha Medical Corporation will hold a board meeting on 29 Oct 2026 to consider Q1 FY27 unaudited standalone financial results. The trading window is closed from 1 Oct to 31 Oct 2026.
Indraprastha Medical Corporation Other Announcement
The Company has filed its quarterly shareholding pattern as mandated by Regulation 31(1)(b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Indraprastha Medical Corporation Annual General Meeting
Indraprastha Medical Corporation Ltd announced voting results for its AGM held on September 24, 2026. Shareholders approved a dividend of Rs. 4.00 per equity share.
- Value
- ₹36.67 Cr
Indraprastha Medical Corporation Annual General Meeting
Indraprastha Medical Corporation Limited held its 38th AGM on September 24, 2026. Shareholders considered resolutions including a Rs. 4.00 per share dividend declaration.
Indraprastha Medical Corporation Annual Report
Indraprastha Medical Corporation Limited has released its Annual Report for FY 2025-26. The 38th Annual General Meeting is scheduled for September 24, 2026.
Indraprastha Medical Corporation Annual General Meeting
Indraprastha Medical Corporation will hold its 38th AGM on September 24, 2026. The company has fixed September 18, 2026, as the record date for dividend and e-voting.
Other board meeting date announcements
All →Tapi Fruit Processing Board Meeting Date
Tapi Fruit Processing will hold a board meeting on November 3, 2026 to consider unaudited standalone and consolidated half-yearly results for September 2026. Trading window closes from October 1 to November 5, 2026.
Parag Milk Foods Board Meeting Date
Parag Milk Foods has notified BSE of a board meeting on 3 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. Trading window closure runs from 1 October to 5 November 2026.
Vedant Fashions Board Meeting Date
Vedant Fashions will hold a board meeting on 5 November 2026 to consider unaudited results for the quarter and half-year ended September 2026. The meeting is a prior intimation, so no results are approved yet.
Dangee Dums Board Meeting Date
Dangee Dums will hold a board meeting on 2 November 2026 to consider unaudited standalone results for the quarter and half year ended 30 September 2026. Trading window closure runs until 4 November 2026.
Relic Technologies Board Meeting Date
Relic Technologies intimated a board meeting on 2 Nov 2026 to consider unaudited standalone and consolidated Q2 results for the period ended 30 Sep 2026. The trading window closes from 1 Oct 2026 until 48 hours after the results are disseminated.
EPL Board Meeting Date
EPL will hold a board meeting on November 4, 2026 to consider September quarter results. Trading window re-opens 48 hours after results are declared.